Nigeria is making significant strides in reducing cancer deaths, both domestically and across the African continent. The country’s National Cancer Control Program has been strengthened, focusing on institutional response, resource allocation, and building oncology workforce and services.
Key initiatives include the Innovative Cancer Medicine (ICM) Demonstration Project, providing free immunotherapy treatment to cancer patients, and the HPV Vaccination Program, aiming to vaccinate 7.7 million girls aged 9-14. The National Institute for Cancer Research and Treatment (NICRAT) is also working to improve cancer care and research, with collaborations with international organizations like the Mayo Clinic.
Despite progress, challenges persist, including limited healthcare infrastructure, low awareness, and financial constraints. Nigeria records approximately 127,000 cancer cases annually, with an estimated 80,000 deaths.
The Federal Government is committed to improving cancer prevention, research, diagnosis, and access to quality care. Plans include establishing and upgrading cancer treatment centers, implementing catastrophic health insurance, and strengthening cancer registries.
NICRAT is working with local and international partners to enhance cancer care and research. The Institute has signed over 20 Memoranda of Understanding (MoUs) with renowned institutions to improve cancer research, clinical care, and public health training.
Nigeria’s efforts serve as a model for other African countries, demonstrating the power of collaboration and commitment in reducing cancer deaths.
